Editorial Board Member - JBBS
Baolin Zhang
Division of Therapeutic ProteinsOffice of Biotechnology Products
FDA/Center for Drug Evaluation and Research
United States
BIOGRAPHY:
Dr. Baolin Zhang is a Senior Investigator and a Product Quality Reviewer in the Office of Biotechnology Products of the Center for Drug Evaluation and Research (CDER) at the US Food and Drug Administration (FDA). He earned his Ph.D. in chemistry from Peking University in China. He has published over 70 original studies in prestigious journals, and presented at numerous scientific and regulatory conferences on the development of therapeutic proteins. He is a recipient of the FDA Scientific Achievement Award, the FDA/CDER Excellence in Mentoring Award, and the FDA/CDER Excellence in Leadership Award.
RESEARCH INTERESTS:
Dr. Baolin Zhang research is mainly focused on cell death, cancer drug resistance, cancer biomarkers, protein glycosylation, therapeutic protein aggregation in human plasma, and bioassays for the functional evaluation of therapeutic protein products.
Other Editorial Board Members - JBBS
Massimo Ciccozzi
National Institute of Health
Rome
Robert R. Redfield
Department of Immunology and Microbiology
University of Maryland
United States
HENGYI XU
State Key Laboratory of Food Science and Technology
Nanchang University
China
Barbara Anne Curbow
Department of Behavioral and Community Health
School of Public Health
University of Maryland
United States
S. Peder Cuneo
Arizona Veterinary Diagnostic Laboratory
University of Arizona
United States
MICHAEL H. A. ROEHRL
Department of Laboratory Medicine and Pathobiology
University of Toronto
Canada
Lihua Song
Chief, Laboratory of Rickettsiology
Beijing Institute of Microbiology and Epidemiology
China
